Micro Market Monitor: Global Hyperspectral Imaging Market
M2 - Fri Dec 12, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/kdmfrn/micro_market) has announced the addition of the "Micro Market Monitor: Global Hyperspectral Imaging Market" report to their offering. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. The report has profiled the leading players of this market along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years, and the strategies adopted by them to sustain and strengthen their position in the global intraoperative imaging market. BrainLAB AG (Germany), IMRIS Inc. (U.S.), Imaging3 Inc., (U.S.), Medtronic Inc., (U.S.), Neurologica Corporation (U.S.), and Siemens Healthcare (U.S.) are some of the key players engaged in this market. Key Topics Covered: 1 Hyperspectral Imaging Market, By Application 2 Hyperspectral Imaging Market, By Application 3 Global Hyperspectral Imaging Market, By Geography 4 Competitive Landscape Companies Mentioned - Applied Spectral Imaging Ltd. (U.S.) - Brandywine Photonics LLC (U.S.) - ChemImage Corp. (U.S.) - Cubert-GmbH (Germany) - CytoViva - FluxData - Galileo Group - GeoMetWatch Corp. (U.S.) - Gilden Photonics Ltd. (U.K.) - Gooch & Housego (U.K.) - Headwall Photonics Inc. (U.S.) - HyVista Corporation Pty Ltd (Australia) - IMEC (Belgium) - ITRES (Canada) - Inc. (U.S.) - Inno-spec GmbH (Germany) - LemnaTec GmbH (Germany) - Merrick & Company (U.S.) - MicaSense - Middleton Research (U.S.) - Raytheon ELCAN optical technologies (Canada) - Resonon - SPECIM (Finland) - Scientific Aerial Imaging - SpecTIR (U.S.) - Surface Optics Corp. (U.S.) - Teledyne DALSA Inc. (Canada) - VK DI Kerschhaggl GmbH (Germany) - Telops (Canada) For more information visit http://www.researchandmarkets.com/research/kd...cro_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MDT: 72.52 (-1.25), RTN: 104.26 (-2.13), IMRS: 0.23 (-0.01)
5 Under-$10 Stocks Setting Up to Trade Higher: Must-See Charts
at The Street - Fri Dec 05, 10:21AM CST
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
CRNT: 1.10 (-0.01), AMKR: 6.31 (-0.14), IMRS: 0.23 (-0.01), NTLS: 3.91 (+0.01), BSDM: 0.38 (unch)
IMRIS completes SYMBIS Surgical System human factors study
PR Newswire - Mon Dec 01, 5:12AM CST
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
PR Newswire - Mon Nov 17, 3:53PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014.
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
Nasdaq stocks posting largest volume increases
AP - Fri Oct 31, 5:04PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
ONCY: 0.61 (+0.03), IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02), FCCO: 11.19 (-0.10), RDI: 12.59 (unch), CDTI: 1.91 (-0.09), ONC.TO: 0.71 (+0.08), DAIO: 3.35 (-0.14), AEGR: 21.09 (-0.22), RDIB: 12.88 (+0.52)
IMRIS neurosurgical suite opens at Boca Raton Regional Hospital
CNW Group - Wed Oct 29, 7:00AM CDT
Marcus Neuroscience Institute becomes first in Florida with both VISIUS iMRI and iCT for intraoperative imaging without patient transport
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
Imris affirms guidance after Q3 reults
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 2:37PM CDT
IMRS: 0.23 (-0.01)
IMRIS' (IMRS) CEO Jay Miller on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 1:01PM CDT
IMRS: 0.23 (-0.01)
Imris misses by $0.06, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 7:06AM CDT
IMRS: 0.23 (-0.01)
IMRIS Reports Third-Quarter 2014 Financial Results
CNW Group - Tue Oct 28, 7:01AM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) today reported financial results for the 2014 third quarter ended September 30, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 third quarter was $8.4 million, or $0.16 per diluted share, on net revenues of $6.9 million. In the prior-year quarter, IMRIS reported a net loss of $3.8 million, or $0.07 per diluted share, on net revenues of $17.8 million. New order bookings were $6.1 million in the third quarter resulting in a backlog of $127.2 million.
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
IMRIS to Hold Third Quarter 2014 Financial Results Conference Call
CNW Group - Wed Oct 22, 3:47PM CDT
IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies
CNW Group - Thu Oct 09, 7:24AM CDT
Learn more about these state-of-the-art products at CNS annual meeting
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)
IMRIS Horseshoe headrest named Life Sciences Alley New Technology Showcase winner
PR Newswire - Tue Sep 30, 7:00AM CDT
Intraoperative neurosurgical imaging solutions from IMRIS among featured medical technologies at upcoming November conference in Minneapolis
IMRS: 0.23 (-0.01), IM.TO: 0.26 (-0.02)